MARKET

STAB

STAB

Statera Biopharma Inc
NASDAQ
0.1231
-0.0019
-1.52%
After Hours: 0.1279 +0.0048 +3.90% 19:58 12/01 EST
OPEN
0.1230
PREV CLOSE
0.1250
HIGH
0.1398
LOW
0.1206
VOLUME
2.08M
TURNOVER
0
52 WEEK HIGH
2.990
52 WEEK LOW
0.0945
MARKET CAP
6.73M
P/E (TTM)
-0.0715
1D
5D
1M
3M
1Y
5Y
12 Health Care Stocks Moving In Wednesday's Intraday Session
Benzinga · 1d ago
Why Richardson Electronics Shares Surged Over 8%; Here Are 55 Biggest Movers From Friday
Benzinga · 4d ago
12 Health Care Stocks Moving In Friday's Intraday Session
Benzinga · 6d ago
Why Lufax Holding Shares Are Trading Lower By Over 11%; Here Are 21 Stocks Moving Premarket
Benzinga · 11/25 12:38
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Benzinga · 11/16 13:08
'Statera Biopharma (Formerly Cleveland Biolabs) Has Been Granted European Patent Number Ep3206708 Titled "Methods And Compositions For The Treatment Of Radiation-related Disorders"' - EPO
Benzinga · 11/15 20:39
Statera Biopharma granted continued listing on Nasdaq
Seekingalpha · 10/27 21:56
Statera Biopharma Receives Positive Nasdaq Listing Determination
Benzinga · 10/27 21:06
More
About STAB
Statera BioPharma, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on developing immunotherapies autoimmune, neutropenia/anemia, emerging viruses and cancers. Its Advanced Immunomodulating Multi-Component System (AIMS) platform is designed to rebalance the body's immune system and restore homeostasis. Its platforms of toll-like receptor (TLR) agonists include R4 and TLR9 antagonists, and the TLR5 agonists, Entolimod and GP532. Through its AIMS platform, the Company develops product candidates, which include STAT-200 and STAT-600 AIMS programs. Its STAT-200 program include STAT-201 is focused on treatment of Crohn’s disease. The Company has clinical programs for Crohn’s disease (STAT-201), hematology (Entolimod), pancreatic cancer (STAT-401) and COVID-19 (STAT-205).

Webull offers kinds of Statera Biopharma Inc stock information, including NASDAQ:STAB real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, STAB stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading STAB stock methods without spending real money on the virtual paper trading platform.